'^October15^!-1'  J   American  Pharmaceutical  Association.  477 
taken  from  the  proceedings  and  files  of  the  association.  The  com- 
mittee recommended  that  the  address  be  released  for  publication 
upon  condition  that  any  journal  publishing  it  be  required  to  publish, 
in  full,  the  report  of  the  committee  concerning  it.  After  some  dis- 
cussion it  was  decided  to  drop  the  entire  matter  from  publication 
and  to  file  the  address  and  the  committee's  report  in  a  safe  place 
in  the  archives  of  the  association. 
At  the  second  session  the  following  report  of  the  nominating 
committee  was  presented  for  election  by  ballot  by  mail  in  the  usual 
manner : 
Nomi)iecs  for  President:  J.  A.  Koch,  Pittsburgh;  Chas.  H. 
La  Wall,  Philadelphia  ;  and  Leonard  H.  Seltzer,  Detroit,  Mich. 
Nominees  for  First  Vice-President:  F.  W.  Nitardy,  Denver, 
Colo. ;  E.  A.  Ruddiman,  Nashville,  Tenn. ;  and  Jacob  Diner,  New 
York. 
Nominees  for  Second  Vice-President :  T.  J.  Bradley,  Boston  ;  W. 
W.  Stockberger,  Washington,  D.  C. ;  and  H.  C.  Christensen,  Chicago. 
Nominees  for  Third  Vice-President :  Frank  Schachleiter,  Ho! 
Springs,  Ark. ;  L.  C.  Lewis,  Tuskegee,  Ala. ;  and  Francis  C.  Hemm, 
St.  Louis,  Mo. 
Nominees  for  Members  of  the  Council:  Three  to  be  elected  :  Chas. 
Holzhauer,  Newark,  N.  J. ;  W.  J.  Teeters,  Iowa  City,  la. ;  C.  B. 
Jordan,  Lafayette,  Ind. ;  Caswell  A.  Mayo,  New  York ;  R.  A. 
Lyman,  Omaha,  Neb. ;  Chas.  E.  Caspari,  St.  Louis ;  O.  F.  Claus, 
St.  Louis ;  G.  F.  Payne,  Atlanta ;  and  John  C.  Wallace,  New  Castle, 
Pa. 
At  the  final  general  session  the  minutes  of  the  council  were  read 
and  approved,  except  as  to  the  subject  of  pharmaceutical  research. 
In  this  matter  the  recommendation  of  the  scientific  section  that  a 
permanent  research  committee  of  ten  members,  with  terms  of  five 
years  each,  be  appointed  by  the  council,  was  adopted.  Among 
the  important  features  of  the  council  minutes  as  approved  was  the 
provision  that  50  per  cent,  of  the  net  profits  from  the  sale  of  the 
National  Formulary  should  be  set  aside  and  be  called  the  American 
Pharmaceutical  Association  Research  Fund. 
At  this  session  President  Wulling  installed  the  officers  elect,  as 
follows :  President,  Charles  Holzhauer ;  First  Vice-President,  Alfred 
R.  L.  Dohme ;  Second  Vice-President,  Leonard  A.  Seltzer  ;  Third 
Vice-President,  Theodore  J.  Bradley ;  Members  of  the  Council, 
Frederick  J.  Wulling,  George  M.  Beringer,  and  Tacob  Diner.  New 
York,  N.  Y. 
